logo
Japan's Dai-Ichi Life to take 15% stake in British insurer M&G

Japan's Dai-Ichi Life to take 15% stake in British insurer M&G

CNA4 days ago

M&G has formed a partnership with Dai-ichi Life Holdings in which the Japanese life insurer plans to buy a 15 per cent stake, sending shares in the British insurer and asset manager up sharply.
The partnership, which makes Dai-ichi M&A's biggest single shareholder, is expected to deliver at least $6 billion of new business flows for M&G and $2 billion of new business flows for Dai-ichi Life over the next five years, M&G said on Friday.
The two companies will "pursue opportunities to co-invest in new asset management capabilities", and M&G will become Dai-ichi Life's preferred asset management partner in Europe as part of the deal.
Andrea Rossi, group CEO of M&G, said that the partnership would enable it to capitalise on "significant private market opportunities across Europe" and give it greater access to the Japanese and Asian market.
M&G shares rose more than 8 per cent in early trading, hitting their highest since June 2021.
Under the deal, Dai-ichi Life will have the right to appoint a director to the board of M&G for as long as it holds at least a 15 per cent shareholding, the British company said.
M&G reported an unexpected rise in annual profit in March, helped by cost-cutting and growth in its asset management business.
Dai-ichi Life earlier in May said it would raise its stake in UK-based Capula Investment Management to 15 per cent, from just under 5 per cent, and in April announced an agreement to buy a 15.1 per cent stake in Australian investment manager Challenger for around $550 million.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Premier League clubs agree to extend price cap on away tickets
Premier League clubs agree to extend price cap on away tickets

CNA

time43 minutes ago

  • CNA

Premier League clubs agree to extend price cap on away tickets

Premier League clubs unanimously agreed on Tuesday to extend the current 30 pounds ($40.56) cap on away ticket prices for a 10th season, the league said in a statement. Since the price cap was introduced in 2016, away game attendance has risen from 82 per cent to 91 per cent. The cumulative away attendance for the 380 matches during the 2024-25 season was 953,420. "The Premier League and clubs recognise the additional costs associated with fans following their team during the season, and the incredible atmospheres they create at matches," the league said in a statement. This comes after fans of several Premier League clubs united under the Football Supporters' Association campaign "Stop Exploiting Loyalty", prompting a ticket price freeze next season from clubs like Liverpool, Brentford, and Manchester City. The new season of England's top flight will begin on August 15 and conclude on May 24, 2026. ($1 = 0.7396 pounds)

Exclusive-Qwant asks French watchdog to take interim action against Microsoft, sources say
Exclusive-Qwant asks French watchdog to take interim action against Microsoft, sources say

CNA

time2 hours ago

  • CNA

Exclusive-Qwant asks French watchdog to take interim action against Microsoft, sources say

BRUSSELS :Qwant has asked France's antitrust regulator to take action against Microsoft for allegedly driving down the quality of the French search engine's results via Microsoft's Bing platform, people with direct knowledge of the matter said. Qwant, which has historically relied on Microsoft's Bing platform, wants the regulator to take interim action against the U.S. tech giant while investigating its complaint, the sources said. The French regulator has sought feedback from other search engines and will likely decide by September whether to take interim action and also whether to open a formal investigation into Microsoft, one of the people said. Competition enforcers only take interim action if there is evidence that a company abuses its market power and has caused serious and immediate harm to the complainant. The French competition enforcer and Qwant declined to comment. "This complaint lacks merit. We are fully cooperating with the Autorite's investigation," a Microsoft spokesperson said, referring to the French watchdog. Smaller European search engines typically rely on their bigger rivals' back-end technology to deliver search and news results. Microsoft is a major player in the search-engine syndication sector but its smaller rivals fear the company will discontinue the service to their detriment. Companies risk fines of as much as 10 per cent of their global annual turnover for breaching French antitrust rules.

Cheaper brain cancer test provides more accurate results in just 2 hours
Cheaper brain cancer test provides more accurate results in just 2 hours

Independent Singapore

time2 hours ago

  • Independent Singapore

Cheaper brain cancer test provides more accurate results in just 2 hours

UK: A cheaper and faster brain cancer test developed by UK researchers can now identify the type of brain tumour in just two hours, offering more accurate results than current methods, PA Media reported. Patients typically wait six to eight weeks to determine the type of brain tumour they have, as samples are sent to central laboratories for genetic analysis. Experts said this long wait can be 'traumatic' and delay treatment like chemotherapy or radiotherapy. With the new test, diagnostic results can be ready in under two hours after surgery, with detailed tumour classifications available within minutes of sequencing. Researchers from the University of Nottingham and Nottingham University Hospitals NHS Trust (NUH) have developed a new method called ROBIN, short for rapid nanopore brain intraoperative classification, which assesses the deoxyribonucleic acid (DNA) from a tumour sample. The test was applied to 50 patients and was in concordance with the standard of care in 90% of cases, according to findings published in Neuro-Oncology . Dr. Matt Loose, a professor of developmental and computational biology at the University of Nottingham, developed a method to sequence specific parts of human DNA using portable sequencing devices from Oxford Nanopore Technologies, which offers real-time analysis. Now, the team has used it to test brain tumour samples genetically. NUH neurosurgeon Dr Stuart Smith said, 'Patients find waiting many weeks for results extremely difficult and this adds to the anxiety and worry at what is already a very difficult time.' Meanwhile, NUH consultant neuropathologist Dr Simon Paine said that the method will be a 'game changer,' pointing to the speed at which results will be available and the degree of accuracy of the diagnosis. Dr. Simon Newman, Chief Scientific Officer of The Brain Tumour Charity, added that the new method will be 'transformative for all patients' as it ensures rapid access to an optimal standard of care and, crucially, removes the uncertainty patients face in waiting weeks for their diagnosis and prognosis. /TISG Read also: New white paper warns of the cost of inaction on youth mental health across APAC

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store